Ketamine Therapy and It’s Potential in Addressing Post Traumatic Stress Disorder (PTSD) and Major Depression
Research has shown promising results for individuals who have not responded to conventional medication protocols. These clinics commonly assist patients with depression, anxiety, post-traumatic stress disorder (PTSD), and pain.
Unraveling Alzheimer’s Disease: Methylene Blue as a Potential Beacon of Hope
Methylene Blue may help address the horrible and debilitating symptoms of Alzheimer’s Disease, dementia, and other cognitive disorders.
ScriptWorks’ Bi-Phasic Gel: A Pawsitive Solution for Dog Ear Infections
Dog ear infections or canine otitis can be a horrible experience for our furry friends. ScriptWorks Rx may have the key to addressing it. East Bay, CA.
Navigating the Changes: Understanding Women’s Hormones and Menopause
Imbalances in women’s hormones are important factors in a woman’s life. We go over how we may learn our hormonal levels and address them.
The Art and Science of Dermatology Compounding at ScriptWorks
Dermatology compounding is a specialized field within pharmacy and medicine that focuses on creating customized medications for various skin conditions.
Nitric Oxide (NO) for Blood Flow & Circulation
Our bodies make Nitric Oxide (NO) naturally at adequate levels when we are young. As we age, we produce less of it — and over time, the blood vessels involved in naturally producing NO become less efficient due to free radical damage, inactivity, and poor diet. At the same time, deterioration of veins and arteries results in overall poor circulation — leading to a myriad of health issues.
Why California Practitioners Write Prescriptions for Compounded Ketamine
Ketamine is a medication that was initially developed as an anesthetic and is commonly used in both medical and recreational contexts. It belongs to a class of drugs known as dissociative anesthetics, which can produce feelings of detachment from one’s surroundings and a sense of dissociation from reality.
A Deeper Look into Low Dose Naltrexone (LDN): Research & Insights
Naltrexone is an opiate receptor antagonist. The 50-mg dose of Naltrexone was approved by the FDA for opioid and alcohol addiction in 1984. At much lower doses (0.5–9 mg per day), it may provide relief to patients suffering from autoimmune diseases, chronic pain, mental health diseases, and inflammation.
Low Dose Naltrexone: A Medical Game Changer
ScriptWorks has spent hours and hours researching and collaborating with healthcare professionals on Low Dose Naltrexone since 2014. Doctors and pharmacists around the world continue to study this fascinating therapy.
Methylene Blue: Evaluating an Old Drug with a New Indication
Lately, our pharmacists have been getting lots of calls about Methylene Blue. I thought we should discuss this in our blog this month.